An oncologist’s perspective on measuring success in the clinic

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Even though cancer center and health system leaders know this deep down, most also find no way better to measure the success of programs and providers than the inscrutable Relative Value Unit, or RVU.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Steven R. Grossman, MD, PhD
Professor of medicine, cancer physician in chief, University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine of USC
Table of Contents

YOU MAY BE INTERESTED IN

The field of surgical oncology has undergone transformative advancements over the last decade. From refining minimally invasive techniques to leveraging immunotherapy and viral oncolytics, our collective goal remains the same: improving patient outcomes while reducing treatment burden. At City of Hope, we have prioritized accelerating the translation of laboratory discoveries into clinical applications, and nowhere is this more evident than in our work with oncolytic viruses, remote surgery, and the integration of AI in surgical decision-making.
Steven R. Grossman, MD, PhD
Professor of medicine, cancer physician in chief, University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine of USC

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login